Atlas Trials

Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies

Clinical trial NCT01781429 · COMPLETED

Trial details

NCT number
NCT01781429
Sponsor
BioMed Valley Discoveries, Inc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced Solid Tumors
Start date
2013-03-01
Primary completion
2018-02-01
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.